The DOI matches its Crossref record; 10 of the 10 references it cites were found in a registry or an index.
Progress on retinal image analysis for age related macular degeneration
Open accessAbstract
Age-related macular degeneration (AMD) is the leading cause of vision loss in those over the age of 50 years in the developed countries. The number is expected to increase by ∼1.5 fold over the next ten years due to an increase in aging population. One of the main measures of AMD severity is the analysis of drusen, pigmentary abnormalities, geographic atrophy (GA) and choroidal neovascularization (CNV) from imaging based on color fundus photograph, optical coherence tomography (OCT) and other imaging modalities. Each of these imaging modalities has strengths and weaknesses for extracting individual AMD pathology and different imaging techniques are used in combination for capturing and/or quantification of different pathologies. Current dry AMD treatments cannot cure or reverse vision loss. However, the Age-Related Eye Disease Study (AREDS) showed that specific anti-oxidant vitamin supplementation reduces the risk of progression from intermediate stages (defined as the presence of either many medium-sized drusen or one or more large drusen) to late AMD which allows for preventative strategies in properly identified patients. Thus identification of people with early stage AMD is important to design and implement preventative strategies for late AMD, and determine their cost-effectiveness. A mass screening facility with teleophthalmology or telemedicine in combination with computer-aided analysis for large rural-based communities may identify more individuals suitable for early stage AMD prevention. In this review, we discuss different imaging modalities that are currently being considered or used for screening AMD. In addition, we look into various automated and semi-automated computer-aided grading systems and related retinal image analysis techniques for drusen, geographic atrophy and choroidal neovascularization detection and/or quantification for measurement of AMD severity using these imaging modalities. We also review the existing telemedicine studies which include diagnosis and management of AMD, and how automated disease grading could benefit telemedicine. As there is no treatment for dry AMD and only early intervention can prevent the late AMD, we emphasize mass screening through a telemedicine platform to enable early detection of AMD. We also provide a comparative study between the imaging modalities and identify potential study areas for further improvement and future research direction in automated AMD grading and screening.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Ranibizumab for Neovascular Age-Related Macular Degeneration
Rosenfeld, P. J., Brown, D. M., Heier, J. S., Boyer, D. S., Kaiser, P. K., Chung, C. Y., & Kim, R. Y. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa054481 · Cited by 5,886
Ranibizumab and bevacizumab for neovascular age-related macular degeneration
(2011) · New England Journal of Medicine · doi:10.1056/nejmoa1102673 · Cited by 2,669
Age-related macular degeneration
Jager, R. D., Mieler, W. F., & Miller, J. W. (2008) · New England Journal of Medicine · doi:10.1056/nejmra0801537 · Cited by 1,379
(2005) · Archives of Ophthalmology · doi:10.1001/archopht.123.11.1484 · Cited by 739
Classifier Technology and the Illusion of Progress
Hand, D. J. (2006) · Statistical Science · doi:10.1214/088342306000000060 · Cited by 723
Klein, R., Klein, B. E. K., Tomany, S. C., Meuer, S. M., & Huang, G.-H. (2002) · Ophthalmology · doi:10.1016/s0161-6420(02)01146-6 · Cited by 363
Epidemiology of proliferative diabetic retinopathy
Klein, R., Klein, B. E. K., & Moss, S. E. (1992) · Diabetes Care · doi:10.2337/diacare.15.12.1875 · Cited by 344
Keane, P. A., Liakopoulos, S., Ongchin, S. C., Heussen, F. M., Msutta, S., Chang, K. T., Walsh, A. C., & Sadda, S. R. (2008) · Investigative Opthalmology & Visual Science · doi:10.1167/iovs.08-1689 · Cited by 145
Occult Choroidal Neovascularization in Age-Related Macular Degeneration: A Natural History Study
Stevens, T. S. (1997) · Archives of Ophthalmology · doi:10.1001/archopht.1997.01100150347006 · Cited by 110
Cited by
A paradigm shift in imaging biomarkers in neovascular age-related macular degeneration
Schmidt-Erfurth, U., & Waldstein, S. M. (2016) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2015.07.007 · Cited by 390
Choi, J. Y., Yoo, T. K., Seo, J. G., Kwak, J., Um, T. T., & Rim, T. H. (2017) · PLOS ONE · doi:10.1371/journal.pone.0187336 · Cited by 282
Ferrara, D., Waheed, N. K., & Duker, J. S. (2016) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2015.10.002 · Cited by 265
Fraccaro, P., Nicolo, M., Bonetto, M., Giacomini, M., Weller, P., Traverso, C. E., Prosperi, M., & OSullivan, D. (2015) · BMC Ophthalmology · doi:10.1186/1471-2415-15-10 · Cited by 48
“Therefore image analysis should be used in conjunction with other clinical biomarkers to enhance diagnosis [5].”
NHE8 is essential for RPE cell polarity and photoreceptor survival
Xia, C.-H., Liu, H., Cheung, D., Tang, F., Chang, B., Li, M., & Gong, X. (2015) · Scientific Reports · doi:10.1038/srep09358 · Cited by 12
Metadata
- Authors
- Kanagasingam, Y., Bhuiyan, A., Abràmoff, M. D., Smith, R. T., Goldschmidt, L., & Wong, T. Y.
- Venue
- Progress in Retinal and Eye Research
- Publisher
- Elsevier BV
- Published
- 2014-01
- Volume
- 38
- Pages
- 20-42
- ISSN
- 1350-9462 (ISSN-L)
- OpenAlex
- W2068939700
- Cited by
- 171
- References
- 10
- FWCI
- 9.51
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Progress on retinal image analysis for age related macular degeneration. https://app.cochat.ai/papers/10.1016/j.preteyeres.2013.10.002
- The paper
- Kanagasingam, Y., Bhuiyan, A., Abràmoff, M. D., Smith, R. T., Goldschmidt, L., & Wong, T. Y. (2014). Progress on retinal image analysis for age related macular degeneration. Progress in Retinal and Eye Research. https://doi.org/10.1016/j.preteyeres.2013.10.002
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.